Svennilson Peter

Latest statistics and disclosures from Svennilson Peter's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NGM, RVMD, NRIX, RAPT, Constellation Pharmceticls I, and represent 90.08% of Svennilson Peter's stock portfolio.
  • Added to shares of these 2 stocks: NRIX (+$236M), NGM.
  • Started 1 new stock position in NRIX.
  • Reduced shares in these 3 stocks: RCUS (-$44M), RAPT (-$37M), GRTS.
  • Sold out of its position in RCUS.
  • Svennilson Peter was a net buyer of stock by $158M.
  • Svennilson Peter has $1.2B in assets under management (AUM), dropping by 2.49%.
  • Central Index Key (CIK): 0001606074

Tip: Access up to 7 years of quarterly data

Positions held by Svennilson Peter consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Svennilson Peter

Svennilson Peter holds 7 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ngm Biopharmaceuticals (NGM) 23.4 $287M 18M 15.91
 View chart
Revolution Medicines (RVMD) 22.7 $278M 8.0M 34.80
 View chart
Nurix Therapeutics (NRIX) 19.2 $236M NEW 6.8M 34.91
 View chart
Rapt Therapeutics (RAPT) 14.8 $181M -16% 5.6M 32.20
 View chart
Constellation Pharmceticls I 10.0 $123M 6.1M 20.26
 View chart
Oric Pharmaceuticals (ORIC) 9.7 $119M 4.8M 25.01
 View chart
Gritstone Oncology Ord (GRTS) 0.2 $2.3M -48% 870k 2.65
 View chart

Past Filings by Svennilson Peter

SEC 13F filings are viewable for Svennilson Peter going back to 2018